Jubilant raises Rs 2000 crore through NCDs

Jubilant Life Sciences this week announced that its shareholders have approved raising of Rs 2000 crore through redeemable non-convertible debentures (NCDs) on private placement basis or rights basis in one or more tranches


Photo Courtesy: www.livemint.com)

In a filing to Bombay Stock Exchange (BSE), Jubilant said that its shareholders have given approval to the board to offer or invite subscriptions for secured/unsecured redeemable non-convertible debentures, in one or more series or tranches, aggregating up to Rs 2000 crore on private placement basis or rights basis.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email